European Human Genetics Conference 2007 June 16 – 19, 2007 ...
European Human Genetics Conference 2007 June 16 – 19, 2007 ...
European Human Genetics Conference 2007 June 16 – 19, 2007 ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Prenatal diagnosis<br />
Po03. Prenatal diagnosis<br />
P0429. Reporting Three Cases Of PND For Alpha thalassemia In<br />
Iran.<br />
V. Lotfi 1,2 , M. Sajedifar 1,2 , P. Fouladi 1,2 , A. Abdolhosseini 1 , F. Shirazi 1 , Z. Shahab<br />
1 , S. Zeinali 1,3 ;<br />
1 Medical <strong>Genetics</strong> Lab of Dr Zeinali, Tehran, Islamic Republic of Iran, 2 Young<br />
Researchers Club of research and science branch of Islamic Azad University,<br />
Tehran, Islamic Republic of Iran, 3 <strong>Human</strong> <strong>Genetics</strong> Unit, Dept of Biotech ,Pasteur<br />
Institute, Tehran, Islamic Republic of Iran.<br />
Each normal person has 4α genes which are shown as αα /αα. Usually<br />
α 2 is more expressed than α 1 therefore deletion of α 2 or mutation on α 2<br />
has more severe effect.<br />
Being carrier alpha thalasemias are usually caused by deletion of one<br />
or two α-globins genes.<br />
Alpha thal genotyped are usally shown like -α/αα (αthal 2); -α /-α or<br />
--/αα (α thal 1 or classical type). --/αα type is seen most in South East<br />
Asia. H-disease is caused by<br />
--/-α form either by deletions or point mutations (e.g. --/α T α ).<br />
Complete absence of 4α genes causes hydrops fetal is which requiring<br />
prenatal diagnose. We have performed three cases of PND for α-thal<br />
so far. In these cases the fetuses were diagnosed carriers (--/αα). In<br />
one case both parents were carrier of Med deletion (-- med /αα). The<br />
Hematological data of parents were:<br />
Father: MCV=62/8 MCH=20/2 Hb=14/1 A 2 = Normal<br />
Mother:MCV=67/9 MCH=20/6 Hb=10/3 A 2 =Normal<br />
At the present time we think only need to perform PND for hydrops<br />
fealties.<br />
Yet we need more strong evidence to do PND since most cases of<br />
Hdisease seen in adults by us were mild enough to exclude PND for<br />
similar cases.<br />
Key words: Alpha thalassemia, Prenatal Diagnosis, H Disease<br />
P0430. Whole-genome expression analysis of amniocytes<br />
G. R. Nagy 1 , B. Győrffy 2 , O. Galamb 3 , B. Nagy 1 , L. Lázár 1 , Z. Bán 1 , B. Molnár 3 ,<br />
Z. Papp 1 ;<br />
1 Semmelweis University, I. Department of Obstetrics and Gynecology, Budapest,<br />
Hungary, 2 Semmelweis University, Szentágothai János Knowledge<br />
Center, Budapest, Hungary, 3 Semmelweis University, II. Department of Internal<br />
Medicine, Cell Analysis Laboratory, Clinical Research Unit of the Hungarian<br />
Academy of Sciences, Budapest, Hungary.<br />
Aims: The objective of our study was to investigate the ability of global<br />
gene expression array analysis from routinely collected amount of amniotic<br />
fluid. We also wanted to search for the differential gene expression<br />
profile of a polygenic disorder, the neural tube defect, which is the<br />
second most common birth defect in the world.<br />
Material and methodology: We analyzed 6-17 mL of amniotic fluid.<br />
Samples were taken from seven pregnant women carrying fetuses with<br />
neural tube defect, diagnosed during ultrasound examination. Control<br />
samples were obtained from pregnant women who underwent routine<br />
genetic amniocentesis because of advanced maternal age (>35<br />
years). Fetal mRNA from amniocytes was successfully isolated, amplified,<br />
labeled, and hybridized to whole-genome transcript arrays. Since<br />
the most significant epidemiological finding with respect to neural tube<br />
defects is the protective effect of maternal periconceptional folic acid<br />
supplementation, we also investigated specific folate-related genes.<br />
Results: The detected differential gene expression profiles between<br />
cases and controls highlighted genes, like SLA, LST1 and BENE<br />
genes, these might be important in the development of neural tube<br />
defects. None of the specific folate-related genes were in the top 100<br />
associated transcripts.<br />
Conclusions: This study demonstrates the ability of global gene expression<br />
array analysis from as small as 6 ml amniotic fluid, allowing<br />
the examination from routinely collected amniotic fluid samples so individual<br />
fetuses can be studied. The analysis of fetal gene expression<br />
differences might get us closer to decipher the complex genetic background<br />
of polygenic disorders.<br />
P0431. Preimplantation genetic diagnosis for autosomal<br />
recessive polycystic kidney disease<br />
N. Gigarel 1 , N. Frydman 2 , P. Burlet 1 , E. Feyereisen 2 , V. Kerbrat 2 , R. Frydman 2 ,<br />
J. Bonnefont 1 , A. Munnich 1 , J. Steffann 1 ;<br />
1 Département de génétique, Necker, Paris, France, 2 Biologie de la reproduc-<br />
1 0<br />
tion, Béclère, Clamart, France.<br />
Autosomal Recessive Polycystic Kidney disease (ARPKD) is one<br />
of the most common hereditary renal cystic disease, and is caused<br />
by mutations in the PKHD1 gene. The diagnosis is often made late<br />
in pregnancy and sometimes at birth. Owing to the poor prognosis,<br />
there is a strong demand for prenatal diagnosis. Preimplantation genetic<br />
diagnosis (PGD) represents an alternative because it is done on<br />
cells taken from in vitro fertilized embryos at the third-day stage. Only<br />
healthy embryos are transferred, avoiding the physical and psychic<br />
traumatism of the termination of pregnancy in the case of an affected<br />
fetus detected later by prenatal diagnosis. We developed a single-cell<br />
diagnostic approach based on haplotype analysis in order to propose<br />
PGD to most couples, whatever the mutations may be.<br />
Six linked markers within (D6S1714 and D6S243), or in close proximity<br />
to (D6S272,D6S436, KIAA0057, D6S<strong>16</strong>62), the PKHD1 gene are<br />
tested in multiplex nested-PCR, using QIAGEN multiplex PCR kit, allowing<br />
identification of embryos carrying the high-risk haplotypes.<br />
PCR analysis was first carried out on 50 single-lymphocytes. Amplification<br />
rate was excellent (100%), with an allele drop-out (ADO) rate<br />
ranging from 0 to 8%. Using this test, 4 PGD cycles were performed<br />
resulting in 18 biopsied embryos. Transferable embryos were obtained<br />
for three cycles, resulting in a pregnancy, and the birth of a healthy boy.<br />
The co-amplification of several loci increases the assay accuracy by<br />
allowing the detection of ADO, recombination and contamination. This<br />
simple diagnostic procedure can be applied to most patients at risk to<br />
transmit ARPKD.<br />
P0432. Non Invasive Prenatal Diagnosis (NIPD): the suitability<br />
of locked nucleic acid (LNA)-modified allele-specific primers for<br />
detection of paternally inherited beta globin gene alleles<br />
G. Dimisianos, J. Traeger-Synodinos, C. Vrettou, E. Kanavakis, A. Mavrou;<br />
University of Athens, Athens, Greece.<br />
Prenatal diagnosis (PND) with CVS sampling and amniocentesis involves<br />
a small risk of pregnancy complications. This may be avoided by<br />
NIPD, which for monogenic diseases is potentially based on detection<br />
of distinct paternally-inherited alleles of cell-free fetal DNA in the maternal<br />
circulation. However, methods for NIPD must address the problem<br />
that fetal alleles exist within an excess of maternal alleles (~5%<br />
versus ~95%) with low total-DNA concentration (~10-100pg/μl). This<br />
study investigates specificity and sensitivity of allele-specific PCR using<br />
LNA-modifed oligonucleotides for the most common Mediterranean<br />
beta-thalassaemia mutation (IVS-I-110G->A, HBB c.93+21G>A) when<br />
present in minority quantities relative to wild-type alleles (20%:80%).<br />
Design of PCR primers included an allele-specific primer (IVS1-110<br />
G>A), LNA-modified at the 3’ nucleotide (mutant base). Inclusion of a<br />
pBR322 RsaI-fragment and pBR322-specific primers monitored PCR<br />
conditions whilst overcoming the problem of co-amplifying genomic regions<br />
present in excess from the maternal genome. Reverse primers<br />
were labelled (Cy5.5), facilitating analysis on an automatic sequencer.<br />
PCR reactions analysed 200 diluted genomic-DNA mixtures with 80%<br />
normal and 20% mutant alleles (M/N), and 100 mutation-free (N/N)<br />
DNA samples (8-80pg DNA /reactions). 32 M/N and 32 N/N DNA samples<br />
were also analysed with non-LNA allele-specific primers under<br />
identical conditions. LNA-modified primers gave 2% false positives<br />
and no false negatives; non-modified primers gave false positive and<br />
negative rates >40%. The pBR322-specific band confirmed correct<br />
PCR conditions in all cases. These results indicate that LNA-modified<br />
allele-specific primers increase specificity and sensitivity.<br />
P0433. Prenatal diagnosis of Carpenter Syndrome<br />
D. F. Albu, A. C. Crenguta, E. Severin;<br />
“Carol Davila” Univ Med Pharm, Bucharest, Romania.<br />
Background: Carpenter syndrome (CS) is a rare genetic disorder also<br />
called acrocephalopolysyndactily. The main features of Carpenter syndrome<br />
are craniosynostosis, congenital heart disease, obesity, extra<br />
fingers and/or toes (polydactyly), genital abnormalities, and short stature.<br />
Carpenter syndrome is an autosomal recessive disorder, for which<br />
the gene has not yet been identified. Objectives: To identify and characterize<br />
both craniofacial and limbs malformations associated with CS.<br />
Patients and Methods: A 28-year-old pregnant Caucasian female was<br />
referred at 21 weeks’ gestation for a routine prenatal ultrasound. Fetal<br />
monitoring was made by ultrasound scans for fetal growth, congenital<br />
malformations, and amniotic fluid volume. We also collected informa-